Published in
Elsevier, European Journal of Cancer, (147), p. 128-139, 2021
DOI: 10.1016/j.ejca.2021.01.025
Links
Tools
Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110)
Journal article published in 2021 by
Kathrin Heinrich 
,
Dominik P. Modest,
Ingrid Ricard ,
Ludwig Fischer von Weikersthal ,
Thomas Decker,
Florian Kaiser,
Ullrich Graeven,
Jens Uhlig,
Michael Schenk ,
Jens Freiberg-Richter,
Bettina Peuser,
Claudio Denzlinger,
Clemens Giessen-Jung,
Arndt Stahler ,
Marlies Michl
and other authors.
,
Dominik P. Modest,
Ingrid Ricard ,
Ludwig Fischer von Weikersthal ,
Thomas Decker,
Florian Kaiser,
Ullrich Graeven,
Jens Uhlig,
Michael Schenk ,
Jens Freiberg-Richter,
Bettina Peuser,
Claudio Denzlinger,
Clemens Giessen-Jung,
Arndt Stahler ,
Marlies Michl
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 